Diagnostic strategies in endometrial cancer

International Congress Series

Volumn 1279, Issue , 2005, Pages 141-148

  Timmerman, Dirk ^a   Van den Bosch, Thierry ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Regionaal Ziekenhuis Heilig Hart Tienen   (Belgium)

Author keywords

Diagnosis; Endometrial cancer; Hydrosonography; MRI; Ultrasound

Indexed keywords

EID: 33646449692     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.02.035     Document Type: Article

References (48)

1. Garcia F., et al. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding. J. Reprod. Med. 48 (2003) 882-888
2. Van den Bosch T., et al. Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women. Obstet. Gynecol. 85 (1995) 349-352
3. Dijkhuizen F.P., et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta analysis. Cancer 89 (2000) 1765-1772
4. Clark T.J., et al. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. Br. J. Obstet. Gynaecol. 109 (2002) 313-321
5. Epstein E., and Valentin L. Rebleeding and endometrial growth in women with postmenopausal bleeding and endometrial thickness <5 mm managed by dilatation and curettage or ultrasound follow-up: a randomized controlled study. Ultrasound Obstet. Gynecol. 18 (2001) 499-504
6. Ferrazzi E., et al. Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study. Ultrasound Obstet. Gynecol. 7 (1996) 315-321
7. Gull B., et al. Can ultrasound replace dilatation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am. J. Obstet. Gynecol. 188 (2003) 401-408
8. Smith-Bindman R., et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280 (1998) 1510-1517
9. Tabor A., Watt H.C., and Wald N.J. Endometrial thickness as a test for endometrial cancer in women with postmenopausal bleeding. Obstet. Gynecol. 99 (2002) 663-670
10. Van den Bosch T., et al. Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy. Am. J. Obstet. Gynecol. 188 (2003) 1249-1253
11. Timmerman D., et al. The pedicle artery sign base don sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet. Gynecol. 22 (2003) 166-171
12. Chan F., et al. Limitations of transvaginal sonography and color Doppler imaging in the differentiation of endometrial carcinoma from benign lesions. J. Ultrasound Med. 13 (1994) 623-628
13. Sheth S., et al. Endometrial blood flow analysis in postmenopausal women: can it help differentiate benign from malignant causes of endometrial thickening?. Radiology 195 (1995) 661-665
14. Sladkevicius P., Valentin L., and Marsal K. Endometrial thickness and Doppler velocimetry of the uterine arteries as discriminators of endometrial status in women with postmenopausal bleeding: a comparative study. Am. J. Obstet. Gynecol. 171 (1994) 722-728
15. De Kroon C.D., et al. Saline contrast hysterography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 110 (2003) 938-947
16. Timmerman D., et al. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am. J. Obstet. Gynecol. 179 (1998) 62-70
17. Widrich T., et al. Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. Am. J. Obstet. Gynecol. 174 (1996) 1327-1334
18. Rogerson L., et al. A comparison of outpatient hysteroscopy with saline infusion hysterosonography. Br. J. Obstet. Gynaecol. 109 (2002) 800-804
19. Alcazar J., Errasti T., and Zornoza A. Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet. Gynecol. Scand. 79 (2000) 321-322
20. Clark T., et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 288 (2002) 1610-1621
21. Romano S., et al. Retrograde seeding of endometrial carcinoma during hysteroscopy. Gynecol. Oncol. 44 (1992) 116-118
22. Schmitz M.J., and Nahhas W.A. Hysteroscopy may transport malignant cells into the peritoneal cavity. Eur. J. Gynaecol. Oncol. 15 (1994) 121-124
23. Rose P.G., Mendelsohn G., and Kornbluth I. Hysteroscopic. Dissemination of endometrial carcinoma. Gynecol. Oncol. 71 (1998) 145-146
24. Egarter C., Krestan C., and Kurz C. Abdominal dissemination of malignant cells with hysteroscopy. Gynecol. Oncol. 63 (1996) 143-144
25. Zerbe M., et al. Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol. Oncol. 79 (2000) 55-58
26. Biewenga P., de Blok S., and Birnie E. Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings. Gynecol. Oncol. 93 (2004) 194-198
27. Tebeu P., et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br. J. Cancer 91 (2004) 720-724
28. Kasamatsu T., et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br. J. Cancer 88 (2003) 245-250
29. Bernard J.P., et al. Saline contrast sonohysterography as first-line investigation for women with uterine bleeding. Ultrasound Obstet. Gynecol. 10 (1997) 121-125
30. T.J. Clark, PhD thesis, Birmingham.
31. Dijkhuizen F.P.H.L.J., et al. Cost-effectiveness of transvaginal sonography and saline infused sonography in the evaluation of menorrhagia. Int. J. Gynaecol. Obstet. 83 (2003) 45-52
32. Clark T.J. Outpatient hysteroscopy and ultrasonography in the management of endometrial disease. Curr. Opin. Obstet. Gynecol. 16 (2004) 305-311
33. Epstein E., et al. An algorithm including results of gray-scale and power Doppler ultrasound examination to predict endometrial malignancy in women with postmenopausal bleeding. Ultrasound Obstet. Gynecol. 20 (2002) 370-376
34. Levine D.A., and Hoskins W.J. Update in the management of endometrial cancer. Cancer J. 8 Suppl. 1 (2002) S31-S40
35. Ludwig H. Prognostic factors in endometrial cancer. Int. J. Gynecol. Obstet., Suppl. 49 (1995) S1-S7
36. Zanetta G. Ultrasound staging of endometrial cancer. In: Timmerman D., Deprest J., and Bourne T.H. (Eds). Ultrasound and endoscopic surgery in obstetrics and gynecology (2002), Springer-Verlag, Berlin
37. Timmerman D., et al. Pre-operative prediction of depth of myometrial invasion in patients with endometrial cancer: evaluation of ultrasound parameters and development of a new logistic regression model. Int. J. Gynecol. Cancer 13 Suppl. 1 (2003) S26
38. Arko D., and Takac I. High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. J. Ultrasound Med. 19 (2000) 639-643
39. Franchi M., et al. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol. Oncol. 76 (2000) 357-361
40. Cheng W.F., et al. Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients. Gynecol. Oncol. 71 (1998) 424-427
41. Cheng W.F., et al. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma. Cancer 82 (1998) 1881-1886
42. Hata K., Hata T., and Kitao M. Intratumoral blood flow analysis in endometrial cancer: does it differ among individual tumor characteristics?. Gynecol. Oncol. 61 (1996) 341-344
43. Testa A., Scambia G., and Caruso A. Letter to the editor. Gynecol. Oncol. 79 (2000) 522-523
44. Kinkel K., et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212 (1999) 711-718
45. Horowitz N., et al. Prospective evaluation of FDG-PET for detecting pelvic and paraaortic lymph node metastasis in uterine corpus cancer. Gynecol. Oncol. 95 (2004) 546-551
46. Ginath S., et al. Tissue and serum CA125 expression in endometrial cancer. Int. J. Gynecol. Cancer 12 (2002) 372-375
47. Kucera E., et al. Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol. Obstet. Investig. 49 (2000) 62-66
48. Todo Y., et al. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am. J. Obstet. Gynecol. 188 (2003) 1265-1272 (erratum 189 (2003) 567)